This most recent twist from the Lykos Therapeutics saga threatens A significant overhaul of the organization’s technique and way, with Musk ally and billionaire investor Antonio Gracias showing to wish to consider the corporation back again towards its nonprofit drug advancement roots and a far more Doblinite philosophy., James writes about why s